Xilio Therapeutics Announces Closing of Initial Public Offering
26 oct. 2021 16h05 HE
|
Xilio Therapeutics, Inc.
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Xilio) a biotechnology company developing tumor-selective immuno-oncology therapies for patients with cancer, today...